Abstract
This article will review the best approaches to neuroimaging for specific ophthalmologic conditions and discuss characteristic radiographic findings. A review of the current literature was performed to find recommendations for the best approaches and characteristic radiographic findings for various ophthalmologic conditions. Options for imaging continue to grow with modern advances in technology, and ophthalmologists should stay current on the various radiographic techniques available to them, focusing on their strengths and weaknesses for different clinical scenarios.
摘要
本文将回顾获取特定眼科疾病神经影像学的最佳方法, 并讨论其特征性的影像学表现。我们回顾了现有文献, 以寻找针对各种眼科疾病获取特征性放射性影像学表现的最佳途径。随着现代科技进步, 影像学方法的选择不断更新, 眼科医生应掌握现有的各种影像学技术, 关注其在不同临床情况下的优缺点.
Similar content being viewed by others
Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Kim JD, Hashemi N, Gelman R, Lee AG. Neuroimaging in ophthalmology. Saudi J Ophthalmol. 2012;26:401–7.
Kakaria AK. Imaging in neuro-ophthalmology: an overview. Oman J Ophthalmol. 2009;2:57–61.
Nucifora PG, Verma R, Lee S, Melhem ER. Diffusion-tensor MR imaging and tractography: exploring brain microstructure and connectivity. Radiology 2007;245:367–84.
Ferreira TA, Saraiva P, Genders SW, Buchem MV, GPM Luyten, Beenakker JW. CT and MR imaging of orbital inflammation. Neuroradiology. 2018;60:1253–66. https://doi.org/10.1007/s00234-018-2103-4.
Erdem E, Angtuaco EC, Van Hemert R, Park JS, Al-Mefty O. Comprehensive review of intracranial chordoma. Radiographics. 2003;23:995–1009.
Chen CC, Chang PC, Shy CG, Chen WS, Hung HC. CT angiography and MR angiography in the evaluation of carotid cavernous sinus fistula prior to embolization: a comparison of techniques. AJNR Am J Neuroradiol. 2005;26:2349–56.
Kontzialis M, Choudhri AF, Patel VR, et al. High-resolution 3D magnetic resonance imaging of the sixth cranial nerve: anatomic and pathologic considerations by segment. J Neuroophthalmol 2015;35:412–25. https://doi.org/10.1097/WNO.0000000000000313.
Lee AG, Johnson MC, Policeni BA, Smoker WR. Imaging for neuro-ophthalmic and orbital disease—a review. Clin Exp Ophthalmol. 2009;37:30–53.
Lennerstrand G, Tian S, Isberg B, Landau Högbeck I, Bolzani R, Tallstedt L, et al. Magnetic resonance imaging and ultrasound measurements of extraocular muscles in thyroid-associated ophthalmopathy at different stages of the disease. Acta Ophthalmol Scand. 2007;85:192–201.
Hoh HB, Laitt RD, Wakeley C, Kabala J, Goddard P, Potts MJ, et al. The STIR sequence MRI in the assessment of extraocular muscles in thyroid eye disease. Eye. 1994;8:506–10.
George A, Haydar AA, Adams WM. Imaging of Horner’s syndrome. Clin Radiol 2008;63:499–505.
Kanter DS, Ruff RL, Leigh RJ, Modic M. See-saw nystagmus and brainstem infarction: MRI findings. Neuroophthalmology. 1987;7:279–83.
Biller J, Pagano RJ. Downbeat nystagmus and pathology at cervicomedullary junction. Neurology 1981;31:781.
Lyall DA, Martinek K, Koshy Z. Downbeat nystagmus as the sole sign of Chiari malformation in goldenhar syndrome. J Pediatr Ophthalmol Strabismus. 2010;47:61–2.
Prasad S. Contin (Minneap Minn) 2014;20:1023–62. https://doi.org/10.1212/01.CON.0000453305.65851.1c.
Becker M, Masterson K, Delavelle J, Viallon M, Vargas MI, Becker CD. Imaging of the optic nerve. Eur J Radio. 2010;74:299–313.
Gass A, Moseley IF. The contribution of magnetic resonance imaging in the differential diagnosis of optic nerve damage. J Neurol Sci. 2000;172:S17–S22.
Hickman SJ, Toosy AT, Miszkiel KA. Visual recovery following acute optic neuritis—a clinical, electrophysiological and magnetic resonance imaging study. J Neurol. 2004;251:996–1005.
Fazzone HE, Lefton DR, Kupersmith MJ. Optic neuritis: correlation of pain and magnetic resonance imaging. Ophthalmology. 2003;110:1646–9.
Khanna S, Sharma A, Huecker J, Gordon M, Naismith RT, Van Stavern GP. Magnetic resonance imaging of optic neuritis in patients with neuromyelitis optica versus multiple sclerosis. J Neuroophthalmol. 2012;32:216–22.
Akaishi T, Sato DK, Nakashima I, Takeshita T, Takahashi T, Doi H, et al. MRI and retinal abnormalities in isolated optic neuritis with myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies: a comparative study. J Neurol Neurosurg Psychiatry. 2016;87:446–8.
Ramanathan S, Prelog K, Barnes EH, Tantsis EM, Reddel SW, Henderson AP, et al. Radiological differentiation of optic neuritis with myelin oligodendrocyte glycoprotein antibodies, aquaporin-4 antibodies, and multiple sclerosis. Mult Scler. 2016;22:470–82.
Kim HJ, Paul F, Lana-Peixoto MA, Tenembaum S, Asgari N, Palace J, et al. MRI characteristics of neuromyelitis optica spectrum disorder: an international update. Neurology. 2015;84:1165–73.
Kim SM, Woodhall MR, Kim JS, Kim SJ, Park KS, Vincent A, et al. Antibodies to MOG in adults with inflammatory demyelinating disease of the CNS. Neurol Neuroimmunol Neuroinflamm. 2015;2:e163.
Kitley J, Leite MI, Kuker W, Quaghebeur G, George J, Waters P, et al. Longitudinally extensive transverse myelitis with and without aquaporin 4 antibodies. JAMA Neurol. 2013;70:1375–81.
Kitley J, Waters P, Woodhall M, Leite MI, Murchison A, George J, et al. Neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies: a comparative study. JAMA Neurol. 2014;71:276–83.
Jurynczyk M, Geraldes R, Probert F, Woodhall MR, Waters P, Tackley G, et al. Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis. Brain. 2017;140:617–27.
Chen JJ, Flanagan EP, Jitprapaikulsan J, López-Chiriboga ASS, Fryer JP, Leavitt JA, et al. Myelin oligodendrocyte glycoprotein antibody-positive optic neuritis: clinical characteristics, radiologic clues, and outcome. Am J Ophthalmol. 2018;195:8–15.
Prasad S, Moss HE, Lee EB, Glisson CC, Galetta SL. Clinical reasoning: a 42-year-old man with sequential monocular visual loss. Neurology. 2008;71:e43–e49. https://doi.org/10.1212/01.wnl.0000327690.66003.0a.
Lee AG, Eggenberger ER, Kaufman DI, Manrique C. Optic nerve enhancement on magnetic resonance imaging in arteritic ischemic optic neuropathy. J Neuroophthalmol. 1999;19:235–7.
Lee AG, Lin DJ, Kaufman M, Golnik KC, Vaphiades MS, Eggenberger E. Atypical features prompting neuroimaging in acute optic neuropathy in adults. Can J Ophthalmol. 2000;35:325–30.
Khan AA, Hussain SA, Khan M, Corbett JJ. MRI findings of bilateral posterior ischemic optic neuropathy in postcardiac transplant patient. Neurologist. 2012;18:313–5.
Kubal WS. Imaging of orbital trauma. Radiographics. 2008;28:1729–39.
Choi SH, Kwon BJ, Na DG, Kim JH, Han MH, Chang KH. Pituitary adenoma, craniopharyngioma, and Rathke cleft cyst involving both intrasellar and suprasellar regions: differentiation using MRI. Clin Radio. 2007;62:453–62.
Flanagan EP, Hunderfund AL, Giannini C, Meissner I. Addition of magnetic resonance imaging to computed tomography and sensitivity to blood in pituitary apoplexy. Arch Neurol. 2011;68:1336–7.
Piotin M, Tampieri D, Rufenacht DA, Mohr G, Garant M, Del Carpio R, et al. The various MRI patterns of pituitary apoplexy. Eur Radio. 1999;9:918–23.
Wilson WB. Meningiomas of the anterior visual system. Surv Ophthalmol. 1981;26:109–27.
Spagnoli MV, Goldberg HI, Grossman RI, Bilaniuk LT, Gomori JM, Hackney DB, et al. Intracranial meningiomas: high-field MR imaging. Radiology. 1986;161:369–75.
Saeed P, Rootman J, Nugent RA, White VA, Mackenzie IR, Koornneef L. Optic nerve sheath meningiomas. Ophthalmology. 2003;110:2019–30.
Avery RA, Fisher MJ, Liu GT. Optic pathway gliomas. J Neuroophthalmol. 2011;31:269–78.
Higgins JN, Owler BK, Cousins C, Pickard JD. Venous sinus stenting for refractory benign intracranial hypertension. Lancet. 2002;359:228–30.
Barboriak DP. Imaging of brain tumors with diffusion-weighted and diffusion tensor MR imaging. Magn Reson Imaging Clin North Am. 2003;11:379–401.
Gregory DG, Pelak VS, Bennett JL. Diffusion-weighted magnetic resonance imaging and the evaluation of cortical blindness in preeclampsia. Surv Ophthalmol. 48:647–50. https://doi.org/10.1016/j.survophthal.2003.08.008.
Politis M, Piccini P. Positron emission tomography imaging in neurological disorders. J Neurol 2012;259:1769–80. https://doi.org/10.1007/s00415-012-6428-3.
Apurva PA, Bipin PM, Kirti PM. Role of PET scan in clinical practice. 2013;68. http://medind.nic.in/gaa/t13/i2/gaat13i2p19.pdf.
Whitwell JL, Graff-Radford J, Singh TD, Drubach DA, Senjem ML, Spychalla AJ, et al. F-FDG PET in posterior cortical atrophy and dementia with lewy bodies. J Nucl Med. 2017;58:632–8. https://doi.org/10.2967/jnumed.116.179903.
Garde N, Skripuletz T, Pul R, Berding G, Weissenborn K, Trebst C. Visual hallucinations in Charles Bonnet syndrome can be seen in fluorodeoxyglucose-PET. J Neuropsychiatry Clin Neurosci. 2011;23:E38–9. https://doi.org/10.1176/jnp.23.4.jnpe38.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Al Othman, B., Raabe, J., Kini, A. et al. Neuroradiology for ophthalmologists. Eye 34, 1027–1038 (2020). https://doi.org/10.1038/s41433-019-0753-z
Received:
Revised:
Accepted:
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41433-019-0753-z
